Copper(II) complexes of coumarin-derived Schiff base ligands: Pro- or antioxidant activity in MCF-7 cells? by MacLean, Louise et al.
Accepted Manuscript
Copper(II) complexes of coumarin-derived Schiff base ligands:
Pro- or antioxidant activity in MCF-7 cells?
Louise MacLean, Dariusz Karcz, Hollie Jenkins, Siobhán
McClean, Michael Devereux, Orla Howe, Marcos D. Pereira,
Nóra V. May, Éva A. Enyedy, Bernadette S. Creaven
PII: S0162-0134(18)30663-9
DOI: https://doi.org/10.1016/j.jinorgbio.2019.110702
Article Number: 110702
Reference: JIB 110702
To appear in: Journal of Inorganic Biochemistry
Received date: 15 November 2018
Revised date: 29 April 2019
Accepted date: 1 May 2019
Please cite this article as: L. MacLean, D. Karcz, H. Jenkins, et al., Copper(II) complexes
of coumarin-derived Schiff base ligands: Pro- or antioxidant activity in MCF-7 cells?,
Journal of Inorganic Biochemistry, https://doi.org/10.1016/j.jinorgbio.2019.110702
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
Copper(II) complexes of coumarin-derived Schiff base ligands: Pro- or antioxidant activity in MCF-7 
cells? 
Louise MacLean,
1
 Dariusz Karcz,
2
 Hollie Jenkins,
1
 Siobhán McClean,
3
 Michael Devereux,
4
 Orla 
Howe,
4 
Marcos D. Pereira,
5
 Nóra V. May,
6
 Éva A. Enyedy,
7 
Bernadette S. Creaven.
1*
 
 
1. Centre of Applied Science and Health, TU Dublin - Tallaght Campus, Tallaght, D24 FKT9.  
2. Department of Analytical Chemistry (C1), Faculty of Chemical Engineering and Technology, 
Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland. 
3. School of Biomolecular and Biomedical Science, University College Dublin, Belfield Dublin 
4.   
4. The Inorganic Pharmaceutical and Biomimetic Research Centre, Focas Research Institute, 
TU Dublin - City Campus, Kevin St, Dublin 8. 
5. Laboratório de Citotoxicidade e Genotoxicidade, Departamento de Bioquímica, Instituto de 
Química, Universidade Federal do Rio de Janeiro, Brazil. 
6. Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok 
körútja 2, H-1117 Budapest, Hungary. 
7. Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 
Szeged, Hungary. 
 
Keywords: Copper complexes, Schiff bases, ROS, Speciation 
Abstract:  
A series of copper(II) complexes of Schiff base-derived ligands (1-7) were studied for their pro- and 
antioxidant behaviour in the MCF-7 human breast cancer cell line. The coordination modes of two of 
the copper(II) complexes were investigated by pH-potentiometry, EPR and UV-Vis spectroscopic 
methods. The solution studies indicated that monomeric species are present in the Cu(II) – L1 system 
at neutral pH, whereas dinuclear species were observed in the case of the Cu(II) – L7 system. This 
difference in speciation was reflected in their relative cytotoxicities with the copper(II) complex of 
L1, showing significant cytotoxicity against MCF-7 cells whilst the complex of L7 was inactive. In 
fact, only three of the seven complexes studied in this series were cytotoxic to MCF-7 cells but this 
cytotoxicity did not correlate with their ability to bind to DNA, cleave DNA or act as a pro-oxidant. In 
contrast to previous copper(II) complexes studied by our group, the compounds studied here do not 
appear to lead to intracellular reactive oxygen species generation at any significant level.  In a yeast-
based assay, all of the copper complexes had the ability to protect Saccharomyces cerevisiae against 
menadione-induced oxidative stress but not hydrogen peroxide-induced stress, indicating a lack of 
catalase activity. Given that the adaptive mechanisms induced by hypoxia in cancer cells have 
selective effects, with a fine-tuned protection against damage and stress of many kinds, particularly 
against oxidative stress, chemotherapeutic compounds which are not pro-oxidants may offer a 
therapeutic advantage.  
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Introduction: 
Living organisms display complex defence mechanisms to protect against endogenous reactive 
oxygen species (ROS), based on antioxidants, enzymes and compounds which, in low concentrations 
dismutate or scavenge ROS. This antioxidant system prevents oxidative damage to cell organelles, 
plasma membranes, nuclear and mitochondrial DNA, and maintains homeostatic balance.
1,2
 However, 
uncontrolled generation of ROS as well as reactive nitrogen species (RNS) have been implicated in 
many diseases including cardiovascular disease,
3
 arthritis,
4
 neurodegenerative disease
5
 and cancer.
6 
With respect to cancer, ROS have been shown to be present at high concentrations in some types of 
cancers, due to the high metabolic activity of the cells.
7
 ROS can cause modification of base pairs 
through abstraction or addition of hydrogen, induction of  DNA strand breaks and DNA cross-linking 
causing DNA mutagenesis and initiating uncontrolled division, the initial step in tumour 
development.
6
 However, numerous studies have also concluded that increasing ROS levels can 
promote oxidative stress-induced cancer cell death.
8
 Thus while the role of ROS in the 
prevention/induction of cancer is a topic of intense debate in general, the idea of using therapies 
which selectively generate oxidative stress in cancer cells was proposed as a possible therapeutic 
treatment for malignant cancers.
9
 Treatments which depend on the generation of ROS within the 
cancer cells for their cytotoxic effects are naturally a cause of general concern given the established 
links between promotion of carcinogenesis and ROS.
10
 Nevertheless a number of clinically used 
chemotherapeutics such as paclitaxel, vinca alkaloids and antifolates are thought to cause cell death 
through the release of cytochrome c and also disruption of the mitochondrial electron transport chain 
leading to increases in intracellular ROS.
11-13
 Procarbazine, which is approved for the treatment of 
lymphoma and primary brain tumours, also acts by increasing ROS within tumour cells.
14 
A series of metal-based compounds, specifically copper(II) complexes of 1,10-phenanthroline, have 
been proposed as possible alternatives to the widely used metallodrug, cisplatin.
15 
These complexes 
have the ability to generate ROS in the presence of oxygen, and the resultant ROS have been shown to 
cause random cleavage in DNA at the point where the complex is intercalated with DNA. More 
recently, other metal-based drugs have been the focus of clinical trials including a series of copper 
complexes known as the “Casiopeina” series which appear to initiate their anticancer effect through a 
ROS mechanism.
16 
Other  copper(II) complexes studied to date as possible chemotherapeutic agents 
are avid intercalators of DNA and also act as chemical nucleases, with their ability to act as nucleases 
attributed  to their redox activity within the cancer cell.
16-18
 A large number of these complexes have a 
square planar N,N’-O,O’ or N,N’-N,N’ coordination geometry around the metal centre as do the 
“Casiopeina” series. We and others have identified copper complexes which have shown considerable 
cytotoxicity against a number of mammalian derived cancer cells lines including human ovarian 
cancer cells (SKOV-3), breast cancer cells (MCF-7), prostate cancer cells (DU145) and colon 
adenocarcinoma cell line (HT29).
19-23
 Their solid-state structures indicate that the majority possess 
square planar geometry around the copper(II) centre. In some cases their anticancer activity has been 
related to their ability to act as chemical nucleases through the generation of ROS. Conversely, a 
number of commercial preparations of copper complexes, namely the veterinary Cu(II) complexes of 
indomethacin which is widely used as an anti-inflammatory treatment in mammals, are thought to 
exert their affects through their ability to regulate oxidative stress and reduce inflammation.
24 
In 
addition, copper(II) complexes of clinically used non-steroidal anti-inflammatory drugs (NSAIDs) are 
often more potent anti-inflammatory agents than either the parent NSAID drug or the uncomplexed 
copper salt.
25,26 
Thus the role of copper complexes, in both the generation of and amelioration of, ROS 
has been established in a number of models and studies.   
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One series of complexes studied by us, coumarin-derived Schiff bases and their copper(II) complexes 
(Fig. 1), were cytotoxic to the breast cancer derived MCF-7 mammalian cell line, at concentrations 
which were comparable to the cytotoxic activity of the commercially used drug, mitoxantrone.
27
 That 
study and other related work on cytotoxic copper complexes with square planar coordination 
geometry prompted us to look at the mechanism of action of coumarin-derived Schiff bases and their 
copper(II) complexes in that cell line. Complexes 2-6 shown in Fig. 1, have a N,O-N’,O’ coordination 
geometry about the copper(II) centre in the solid state but our previous studies had shown that in 
solution at neutral pH, the predominating Cu(II) species formed in solution equilibrium systems by 
some of the Schiff base ligands were largely monomeric with coordination of the ligands through the 
N and the phenolate O
-
.
27
 The free coordination sites are occupied by solvent molecules at low pH, 
while in neutral and alkaline solution, mixed hydroxido complexes are formed. The stabilities and 
coordination modes of the corresponding Cu(II) complexes of various Schiff base ligands did not 
differ significantly, with one exception, the copper(II) complex formed with L4. In this case the 
ligand has an additional OH group which was found to occupy the third equatorial site of the metal 
ion of another monomeric unit, and vice versa, forming a highly stable dimeric complex in the acidic 
pH region. At nearly neutral pH, these bridging OH groups of the dimer are deprotonated. In alkaline 
solution, the binuclear species are replaced by a mixed hydroxido complex with catecholate 
coordination, which is also significantly more stable than the other mixed hydroxido complexes with 
Schiff-base binding mode for the other ligands. The poor aqueous solubility of the other ligands and 
complexes hindered their full investigation so a more water soluble ligand L7 and complex were 
synthesised and their solution behaviour at physiological pH investigated. The pro- or antioxidant 
nature of the complexes was also examined in this study, together with the nature of their interaction 
with DNA. 
Results and Discussion 
Synthesis of Schiff base complexes 
The structures of the ligands and complexes used in this study are given in Fig. 1. The synthesis and 
characterisation of the ligands L1-L6 and complexes 2-6 have been previously reported.
27,28
 L4 had 
the greatest solubility in a range of solvents and also had displayed a different coordination mode at 
physiological pH to the other Schiff bases in our previous study and thus a trihydroxy Schiff base, L7, 
was synthesised and its Cu(II) complex isolated. The ligands were prepared in two steps, firstly 
through the synthesis of a coumarin-based compound 7-amino-4-methylcoumarin via a Pechmann 
condensation reaction between an aromatic phenol, 3-aminophenol, and a β-keto ester, ethyl 
acetoacetate. 7-amino-4-methylcoumarin was then reacted with various substituted aldehydes to 
generate a series of Schiff bases, L1-L7, (Scheme 1).  Complex 1 had not been isolated in pure form 
in our previous studies but was successfully isolated for these studies and included here. Details of the 
synthesis and analytical data are given in Supplementary Information. We were unable to isolate 
crystals of the complexes, though a related complex previously reported by our group, showed a 
mononuclear Cu(II) centre bound to two Schiff base ligands in a distorted square planar coordination 
environment around the metal centre.
28
 Table 1 compares the ligand IR bands to the bands of the 
corresponding complexes for complexes 1 and 7. For complex 7 the imine stretch vibration 1639 cm
-1
 
in the free ligand was observed at a slightly higher frequency in the Cu(II) complex at 1643 cm
-1
, 
indicating coordination of the Schiff base ligands may be via the imine nitrogen. The C–O values for 
the complexes undergo a blue shift in the complex, from 1296 cm
–1
 to 1312 cm
–1
, implying 
coordination via the hydroxylato O of the Schiff base ligands. However, the imine band at 1624 cm
-1
 
in L1 was unresolved from the C=C carbon band upon complexation. A band at 1296 cm
-1
 shifted to 
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1312 cm
-1
 upon complexation and was assigned to C–O stretch of the phenolate group. The close 
similarity of the latter IR bands to those of the complexes previously isolated and to the complex 
characterised by X-ray crystallography, indicated that the structure in the solid state of the complex 1 
is likely to have a distorted square planar N,O-N’,O’ coordination mode to the copper(II) centre. The 
solid state structure of complex 7 is likely to be polymeric in nature with binding to both catecholate 
and imine moieties in the structure.   
 
Proton dissociation processes and fluorescence of the studied ligands (L1, L7) 
A series of Schiff base-derived coumarin ligands were previously studied including L1, L4 and L5
 
(Fig.1),
 27
 but solubility issues had prevented the study of the other Cu(II)–ligand systems. The pKa 
value of L1, which contains an ethoxy group in the R
1
 position, was re-determined with additional 
experimentation and is in good agreement with the published data. Additional EPR data for L1 were 
recorded for this work to confirm the data from previous studies. L7 possesses two additional 
hydroxyl groups at R
1
 and R
2
 positions compared to the core molecule. Due to the insufficient water 
solubility of the ligands the studies were performed in an 80% (v/v) dimethyl sulfoxide (DMSO)/H2O 
solvent mixture. pKa values of these ligands have been determined by pH-potentiometry and UV-
visible (UV-vis) spectrophotometry (Table 2).  
Compound L1 has only one dissociable proton attributed to the OH moiety that can be liberated in the 
studied pH range (2‒14.5), while L7 has two additional pKa values due to the presence of the two 
extra hydroxyl groups. Both ligands display intense absorption bands in the UV-vis region due to the 
extended conjugated electronic system of the imine and coumarin moieties (representative spectra are 
shown for L7 in Fig. 2.a). Deprotonation of the phenolic OH groups results in characteristic spectral 
changes, namely the development of a strong band at the 400-470 nm range. The second and third 
deprotonation steps of L7 are strongly overlapping at high pH, thus a pKa value could be determined 
only for the first deprotonation process via the deconvolution of the spectra up to pH 10.4 (Figs. 
2b,c.). Notably, the possible O2 sensitivity of the pyrogallol moiety of L7 makes the pH-
potentiometric results more reliable compared to UV-Vis.   
The pKa of the core molecule (R
1
, R
2
 = -H) is somewhat higher (9.66)
27 
than the pK1 values of L1 and 
L7 due to the presence of the ethoxy and especially the hydroxyl groups, respectively. pK2 and pK3 
values of L7 are fairly high, most probably as a result of the formation of strong hydrogen bond 
between the phenolate O
‒
 and the adjacent OH group. Compounds L1 and L7 exhibit strong 
fluorescence similarly to the analogous compounds.
27
 However, the emission intensities seem to be 
dependent on the substituents as L7 is not as fluorescent as L1 (Fig. 3).  
Complex formation with Cu(II) ions 
Complex formation processes of L1 and L7 with Cu(II) ions were also studied by the combined use of 
pH-potentiometry and EPR spectroscopy in a 80% (v/v) DMSO/H2O solvent mixture. Representative 
titration curves are shown for the Cu(II) ‒ L7 system in Fig. 4. Although stability constants for the 
Cu(II) complexes of L1 were determined by pH-potentiometry in our former work,
27
 measurements 
were repeated and completed by the EPR titrations. The overall stability constants (log) and pKa 
values of the Cu(II)-ligand systems obtained by pH-potentiometry which give the best fit to the 
experimental data are listed in Table 2. The titration curves suggest the formation of a large amount of 
mixed hydroxido complexes in basic solution with L1, therefore [CuLH‒1] and [CuLH‒2]
‒
 are 
considered as [CuL(OH)] and [CuL(OH)2]
‒
 species. However, formation of mixed hydroxido 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
complexes is also probable in the case of L7, but deprotonation of a coordinated water molecule or 
the further hydroxyl groups at positions R
1
 and R
2
 cannot be distinguished on the basis of pH-
potentiometric titrations. It should be noted that only the formation constants for complexes in which 
the metal-to-ligand ratio is 1:1 could be calculated. 
In order to confirm the speciation model obtained by the pH-potentiometric measurements, and to 
elucidate the coordination modes, EPR spectroscopy was applied at room temperature and at 77 K. A 
pH-dependent series of experimental and simulated frozen solution EPR spectra for the Cu(II) ‒ L1 
system are depicted in Fig. 5, and EPR spectroscopic data obtained from the simulation are given in 
Table 3.  The slow rotation of the complexes resulted in broad room temperature spectra which were 
not simulated (Figure S4.1).  It is noteworthy that there was no indication of the formation of any bis-
ligand complexes even at higher ligand excess under the conditions used here. The intensity of the 
EPR signal significantly decreased at pH > 11 in the pH-range of the formation of the [CuL(OH)2]
‒
 
species as the concentration distribution curves shown in Fig. 6 and which are denoted by black lines. 
This phenomenon indicated that the [CuL(OH)2]
‒
 species is most probably a dimeric species, with  
composition [Cu2L2(OH)4]
2‒
 as exchange interaction of close copper ions results in the disappearance 
of the EPR signal. Therefore the pH-potentiometric data were re-evaluated by incorporating the latter 
dimeric species into the speciation model.  
The stability constants (in model II) are collected in Table 2, and new concentration distribution 
curves were computed (in Fig. 6, with grey lines). Simulated anisotropic EPR spectra for Cu(II),  
[CuL]
+
 and [CuL(OH)] are shown in Fig. 7. These spectra and the determined EPR parameters (Table 
3) for the Cu(II) – L1 complexes are fairly similar to those of the core compound (R1, R2 = -H) 
suggesting similar coordination modes. Thus in [CuL]
+
 the coordination of the phenolate oxygen and 
the Schiff-base nitrogen is very feasible (though nitrogen splitting is not resolved), [CuL(OH)] 
contains a hydroxido ligand in addition, for which one nitrogen splitting was taken into account, while 
[Cu2L2(OH)4]
2‒
 is a hydroxido bridged EPR-silent [(CuL(OH))2(µ-OH)2]
2‒
 species.  
In the case of the Cu(II) – L7 system room temperature spectra were recorded. However, EPR 
spectroscopy could not be used as from pH 4 - 15 the signal intensity decreased completely (Figure 
S4.2). The samples were back-acidified and the signal of the free Cu(II) ions were regained 
suggesting that no reduction of Cu(II) took place in the basic pH range. This indicates the formation 
of dimeric or oligomeric complexes. We propose that the OH group on the R
1
 position is able to bind 
to another copper complex and vice versa forming an EPR-silent dimer species.  Therefore the pH-
potentiometric data were fitted with the assumption of the formation of dimeric complexes in solution 
as well and data are shown in Table 2 (model II). Using the stability constants obtained from both 
models, distribution curves were calculated for the Cu(II) – L7 system (Fig. 8).  
Based on the calculations we can conclude that complexes [CuL]
+
 and [CuL(OH)] are present in the 
Cu(II) – L1 system at neutral pH, while at the same pH [Cu2L2H2]
2+
 and [Cu2L2H2] species exist in the 
case of Cu(II) – L7. In the latter two complexes the protons can be attributed to the ligand’s non-
coordinating phenolic OH groups. Formation of bis complexes was not observed in solution. The 
complex formation starts at much lower pH values with L7 indicating the higher stability of the Cu(II) 
– L7 complex relative to the Cu(II) – L1 system. Given that the dominant species in solution at 
neutral pH seem to be quite different for the two complexes, with the coordination of L1 to Cu(II) 
ions similar to the previously studied coumarin-derived Schiff bases and L7 coordination to Cu(II) 
ions similar to the previously studied L4, it would be interesting to compare their relative bioactivities 
to each other and to that of all of the previously synthesised complexes.  
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Cytotoxicity studies 
Previous studies on coumarin derivatives and their Cu(II) complexes isolated by our group have 
shown considerable anticancer activity against a number of cell lines.
20,28,29 
The cytotoxicity of ligands 
L1-L6 and complexes 2-6 was previously assessed against MCF-7 human breast cancer cells using 
methylthiazolyldiphenyltetrazolium bromide-based assay (MTT)
20
 (Table 4) and for comparison are 
presented here with the new data. The most cytotoxic compounds were complexes 3 and 6 showing 
IC50 values of 34.5+6.0 µM and 79.8+5.0 µM respectively. The positive control used in this study was 
mitoxantrone, approved for use in the treatment of metastatic breast cancer and to which MCF-7 cell 
lines are sensitive.
30
 The enhanced solubility of complex 7 did not result in a more cytotoxic 
compound but the cytotoxicity of complex 1 was comparable to mitoxantrone. Solution studies had 
shown that upon dissolution of the complexes it’s likely in all cases that either monomeric or dimeric 
species are formed, therefore a stoichiometric amount of free ligand is also present in all solutions 
tested. Hence, the free ligands and the free copper salt were assayed in all studies carried out here. 
None of the ligands, including L1 and L7, or the free copper salt were cytotoxic to MCF-7 cells.  
Determination of SOD and CAT mimetic ability in a cell-free system 
The generation of hydroxyl radicals through the ability of the complexes to dismutate superoxide to 
hydrogen peroxide, which can then undergo Fenton chemistry to generate highly reactive hydroxyl 
radical has been proposed to be intimately linked to the subsequent DNA damage resulting in cell 
death. The most widely used method of determining the superoxide dismutase (SOD) activity of a 
compound is via a nitro blue tetrazolium (NBT) assay which utilises xanthine–xanthine oxidase as a 
superoxide generator.
19,31 
Initially complexes 2-6 and ligands L2-L6 were tested for their ability to 
inhibit the reduction of NBT to blue formazan by scavenging superoxide radicals, which were 
generated by xanthine oxidase during the conversion of xanthine to urate. Whilst none of the ligands 
showed any SOD activity, all of the tested complexes did (Table 5). The complexes had a much lower 
catalytic efficiency than native CuZn-SOD, which has an IC50 value of 0.04 µM,
32 
and nearly all of 
these complexes exceeded the SOD activity of the marketed veterinary drug, 
[Cu2(indomethacin)4(H2O)2], a dinuclear copper complex which has an IC50 value of 1.31 μM.
32
 
The SOD-mediated dismutation of O2
.-
 species generates H2O2, which in turn may undergo catalase-
mediated decomposition to H2O and O2. A study of Fe(III), Cu(II) and Mn(II) complexes containing 
the (N,N,N,O) donor ligand 1-[bis(pyridine-2-ylmethyl)amino]-3-chloro-propan-2-ol (HPCINOL) 
showed that all three complexes behaved as SOD and CAT mimics and the Fe(III) complex exhibited 
the highest protective effect, followed by Cu(II) and Mn(II).
33
 In terms of the complexes acting as 
DNA nucleases, their ability to disproportionate H2O2 to oxygen and water, would argue against these 
complexes being good nucleases. Reasonable catalase activity could only be recorded for complex 3 
(Table 5), which was identified as the most cytotoxic compound. At the time of these studies, 
complex 1 was not available in pure form. Its more recent isolation together with the newly 
synthesised complex 7 allowed the determination of all of the complexes’ antioxidant activity in a 
yeast-based assay similar to that used to assess the SOD and CAT activity of the copper, manganese 
and iron complexes mentioned above.
 33,34
 
Antioxidant activity of complexes 1-7 in wild type cells  
Saccharomyces cerevisiae is a facultative anaerobe, with the ability to respire aerobically and 
anaerobically in the absence of oxygen. It has an inducible stress response which, similar to 
mammalian cell systems, activates genes encoded for SOD and CAT enzymes when exposed to 
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superoxide and hydrogen peroxide respectively.
21,33,34
 This yeast species has been shown to be a good 
model for determining the SOD and CAT-like activity of metal-based complexes.
33,34
  
Wild type cells were grown in glucose rich media to mid-log phase of growth, as at this point, the 
natural SOD and CAT defences are minimal as they are cultured under fermentative conditions.
33-35
 
Therefore, any SOD or CAT activity observed will be, as far as possible, the result of the antioxidant 
capability exhibited by the complex, rather than the yeast cells own ROS defence enzymes. In the 
positive control, cells were treated with sub-lethal concentrations of menadione or hydrogen peroxide 
to induce an oxidative response. Test conditions involved cells which were pre-treated with 
compounds and subsequently treated with stressor to evaluate any potential protective effects of the 
metal complexes. The viable cell count recorded for the negative control, where cells were allowed to 
grow freely without stressor or complex pre-treatment, represented 100% survival and the positive 
control and complex treated cells were calculated as a percentage of this. DMSO, the solvent which 
was used to dissolve the complexes at a concentration of 14 mM, was also tested and showed no 
ability to protect against stress in either wild type cells or either of the mutant cells strains 
(Supplementary Information).  
 
All Schiff base complexes 1-7 showed statistically significant SOD activity in the wild type studies (P 
<0.001) at 100 µM of complex relative to the positive control, Fig. 9 a) and b). Surprisingly, given the 
results presented in Table 5 above, none of the complexes 1-7, Fig. 10 a), b) and c), showed ability to 
protect cells against hydrogen peroxide-induced stress. The Schiff base ligands and copper salts 
demonstrated no ability to protect the cells against menadione-induced superoxide stress or hydrogen 
peroxide-induced stress, indicating that they are neither SOD nor CAT mimics (Supplementary 
Information). 
As the complexes had only shown SOD activity in the wild type cell studies, three of the complexes, 
4-6, were studied to monitor if the complexes could demonstrate SOD activity in the SOD mutant 
model. As the mutants are more sensitive to oxidative stress due to diminished defences,
33,34
 a lower 
concentration of stressor was used to treat the mutant cells compared to the wild type cells, but all 
other conditions in the individual assays remained the same. The antioxidant activity of DMSO was 
also tested as the vehicle control.  All three complexes showed statistically significant ability to 
protect the sod1∆ mutant cells from menadione-induced oxidative stress, (P = 0.0073, 0.0406, 0.0080 
for 4, 5 and 6 respectively) (Fig. 11).  
ROS activity: Measurement of intracellular oxidative stress 
The fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate, (H2DCFDA), was utilised in 
detecting ROS produced by these complexes in MCF-7 cells, where H2DCFDA is oxidised to 
fluorescent 2',7'-dichlorofluorescein (DCF) in the presence of oxidants. Results are then expressed as 
increases in cellular ROS levels after exposure to test compound relative to fluorescence levels in 
untreated cells and compared to a solvent control and the positive control, tert-butyl hydroperoxide 
(TBHP). TBHP, is an organic source of hydrogen peroxide, and is used at a concentration of 0.5 µM 
to induce oxidative stress in MCF-7 cells.  
L1-L7 showed no discernible ability to induce ROS generation in MCF-7 cells (Supplementary 
Information) and five of the seven Schiff base-derived complexes, 1, and 4-7, had the ability to 
exhibit concentration dependent ROS generation in MCF-7 cells but only at relatively high 
concentration with one exception, complex 1 (Fig. 12). Complex 1 induced ROS at the lower 
concentration of 12.5 µM and upwards at 180 minutes. Complexes 4 and 7 had the least ability, with 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
ROS induction only apparent after 180 minutes at 50 and 100 µM concentrations. None of the Schiff 
base-derived complexes induced ROS at less than 120 minutes of incubation, with complexes 5 and 6 
inducing ROS at 100 µM after 120 minutes. ROS generation is a well-established feature of 
copper(II) complexes and many such  complexes generate considerable ROS at shorter timescales and 
at much lower concentrations than the complexes assessed here.
19, 23,
 
38-40
 
 
DNA binding properties 
The yeast-based assays described above identified that all of the complexes had SOD mimetic activity 
but no catalase mimetic ability and therefore the reaction of the complexes with superoxide may lead 
to the generation of increased levels of hydrogen peroxide in the cell. Given the ubiquitous presence 
of catalytic amounts of Fe(II) in living systems, hydrogen peroxide could then react via Fenton 
chemistry to generate hydroxyl radicals.  As copper complexes are thought to most likely initiate their 
cytotoxic effect through oxygen-dependent or -independent DNA cleavage after intercalation with 
DNA, the DNA binding properties of the complexes were investigated.
 
The most well-known types of 
copper complex-based nucleases are those incorporating 1,10-phenanthroline (phen) such as 
[Cu(phen)2]
2+
 and copper(II) complexes of (N,N,O,O) ligands.
 19, 23,
 
38-40 
The ability of the ligands and 
complexes to bind to DNA was assessed using a competitive ethidium bromide (Et
+
) fluorescence 
displacement assay using CT-DNA (calf-thymus, ultrahigh purity) which allowed comparison with 
the known DNA intercalator actinomycin D and the DNA minor groove binder pentamidine.
36,37
 None 
of the ligands showed any ability to interact with D A and only complexes 6 and 7 showed 
reasonable ability to interact, though not as avidly as actinomycin D, (Table 6), (full data given in 
Supplementary Information) or indeed to related copper(II) square planar complexes previously 
published. 
DNA nuclease ability 
The ability of a complex to bind to DNA is not always followed by the ability to have nuclease 
activity and therefore all of the complexes and ligands were also assessed for their ability to cleave 
DNA. The oxidative DNA cleavage of the ligands and their copper(II) complexes were measured in 
the presence of added reductant using supercoiled (SC) pBR322 DNA. There was no observed 
nuclease activity for any of the ligands up to a concentration of 100 µM and indeed even at 100 µM, 
limited cleavage was noted for a few of the complexes (Supplementary Information). The positive 
control in the assay was 20 µM [Cu(phen)2]2
+
, a complex known to cleave DNA. We have previously 
reported that copper(II) complexes with square planar coordination geometry have shown DNA 
nuclease ability similar to that of [Cu(phen)2]
2+
.
19, 39, 40
 Thus the lack of nuclease ability of these 
complex, given the cytotoxicity of complexes 1, 3 and 6, was surprising and indicates that the 
cytotoxicity of these complexes is unlikely to be related to nuclease activity. 
Conclusions 
The pro/antioxidant behaviour of a series of copper(II) complexes of coumarin-derived Schiff bases 
was studied in order to evaluate their potential as inflammatory modulators to probe the basis of their 
cytotoxicity in MCF-7 cells. Two of these complexes had shown anticancer activity in previous 
studies and a further two complexes were added to this study, primarily as the better solubility of their 
ligands allowed for speciation studies using spectroscopic and potentiometric techniques. Whilst the 
solid state analytical data for the complexes indicated that the copper ion was likely coordinated to 
two Schiff base ligands via 2×(N,O) donor set, the formation of bis complexes was not observed in 
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solution. Instead the solution studies indicated that mono species [CuL]
+
 and [CuL(OH)] are present 
in the Cu(II) – L1 system at neutral pH, similar to the speciation determined for Cu(II) – L5 system 
and other related Schiff bases ligands which were measured previously.
27
 Dinuclear species 
[Cu2L2H2]
2+
 and [Cu2L2H2] were observed in the case of ligand L7, and previously for L4
27
. While for 
L1 and L5, the Cu(II) was found to bind to the imine nitrogen and phenolic oxygen of the ligand 
giving an N,O binding mode, Cu(II) - L4 was suggested to have a O,O binding mode to two 
neighbouring phenolic oxygens, which may also be the case for Cu(II) – L7 due to the presence of 
three neighbouring hydroxyl groups, but due to EPR silence over a wide pH range, the exact binding 
mode could not be established. Unfortunately the solubility of the other ligands in solution did not 
allow for the study of their speciation. Thus, while the complexes studied here may be similar in 
structure to other copper-based chemotherapeutics in the solid state, their solution behaviour would 
suggest that they undergo partial anation or dimerisation at physiological pH, with dimerization likely 
if O,O binding mode is facilitated by the presence of additional hydroxy groups.  
Complex 1 had considerable activity against the MCF-7 breast cancer cell line whilst complex 7 was 
inactive. Previous studies had indicated that complexes 3 and 6 were cytotoxic to the same cell line. 
Copper complexes studied by us and other, also using MCF-7 cells, had shown that these complexes 
had the ability to act as ROS generators and chemical nucleases therefore this study investigated 
whether similar behaviour was apparent for the complexes here.  Complex 6 and 7 were the only 
complexes with DNA binding ability but neither 6 nor 7 showed any nuclease activity despite 
showing DNA binding properties and this is probably related to their limited ability to generate ROS. 
Significant ROS generation was only observed for complex 1, and was limited for complexes 4-7 but 
none of the complexes showed significant nuclease activity. 
Thus three of the seven complexes had shown cytotoxicity against the MCF-7 cell line which did not 
correlate with their ability to bind to DNA, act as a pro-oxidant or have nuclease activity, a mode of 
action previously ascribed to copper(II) complexes studied by our group. A number of the complexes 
had demonstrated ability to act as SOD and catalase mimics in cell-free assays, particularly complexes 
2-4. In contrast, in a yeast–based assay the copper complexes only had the ability to protect S. 
cerevisiae against menadione-induced oxidative stress and not hydrogen peroxide-induced stress, 
indicating a lack of catalase activity. The ability to act as SOD mimetics is considered to be an 
important therapeutic strategy given that the product of SOD is hydrogen peroxide, a pro-oxidant. In 
the compounds studied here though, the action of these compounds in MCF-7 cells does not appear to 
lead to generation of ROS in cells at a high level and will require further studies on our part to 
elucidate the exact mechanism of action.   
Therefore the anti-cancer activity of these Schiff base complexes does not seem to be similar to other 
related copper complexes. Nevertheless, given the hypoxic nature of many tumours, the complexes 
identified here may have advantages as chemotherapeutic agents over other copper complexes 
identified, as their mechanism of action may not be oxidant dependent. The adaptive mechanisms in 
cancer cells induced by hypoxia have a selective effect on cells, with a fine-tuned protection against 
damage and stress, particularly against oxidative stress, thus chemotherapeutic compounds which are 
not pro-oxidants may offer a new therapeutic approach. Currently we are investigating the 
cytotoxicity of these complexes under normoxic, hypoxic and anoxic conditions to establish if their 
toxicity is related to oxygen concentrations in the cell.  
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Experimental details 
General  
All chemicals and solvents were purchased from Sigma Aldrich Ireland, Ltd, unless otherwise stated. 
All chemicals and solvents for the synthesis of the ligands and complexes were reagent grade and 
used without further purification. CuCl2 stock solution was made by the dissolution of anhydrous 
CuCl2 in water and its exact concentration was determined by complexometry through the EDTA 
complex. All solvents were of analytical grade and used without further purification. Doubly distilled 
Milli-Q water was used for sample preparation.  
For the studies on wild type strain of S. cerevisiae cells, chemicals and solvents were purchased from 
Sigma Aldrich Brazil, Ltd, were of reagent grade and were used without further purification. 
Dehydrated media was purchased from Becton, Dickinson and Company, Brazil and were prepared in 
distilled water. Cultures were grown in a New Brunswick Scientific Innova®44 Incubator Shaker at 
160 rpm 28 ºC.  
 
Minimum Essential Medium Eagle (Sigma Aldrich, M2279), 1% v/v L-glutamine 1% v/v (Sigma 
Aldrich, G7513), penicillin-streptomycin solution containing 10000 units penicillin and streptomycin 
10 mg/mL (Sigma Aldrich, F4333), 10% v/v Fetal Bovine Serum 1% v/v (Sigma Aldrich, F7524), 
sodium pyruvate 100 mM solution (Sigma Aldrich S8636), 1% v/v MEM Non-Essential Amino Acid 
solution 100X (Sigma Aldrich, M7154), T75 cm
2
 tissue culture flasks (Corning, 430641U), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, (MTT) (Sigma Aldrich, M5655), 
cisplatinum(II) diamine dichloride (Sigma Aldrich, P4394), Poly-l-lysine (Sigma Aldrich, P4707), 
DMSO for molecular biology (Sigma Aldrich, D8418), Gibco MEM phenol red-free media 
(Biosciences, 51200046), Nest Biotech 96 well clear cell culture plates (Lennox Nest, APV500020), 
black-sided clear-bottomed 96 well plate (Corning, 3603), 2',7'-dichlorodihydrofluorescein diacetate, 
H2DCFDA, (Thermofisher Scientific, D399), tert-butyl hyperperoxide, TBHP, (Sigma Aldrich, 
458139) calf thymus DNA CT-DNA (Sigma Aldrich, D1501), 1 Kb DNA ladder (Invitrogen, 10787-
018), supercoiled pBR322 plasmid DNA (Roche, 10481238001), Ultrapure Agarose, (Invitrogen, 
16500-100), Ultrapure 10X TAE buffer (Invitrogen, 15558-026), Hepes buffer solution (Gibco, 
15630-056). [Cu(phen)2]
2+
, as
 
[Cu(1,10-Phen)2](NO3)2), was kindly donated by Dr Andrew Kellet of 
School of Chemical Sciences and the National Institute for Cellular Biotechnology, Dublin City 
University, and the synthesis of which has been previously published.
41 
Infrared spectra were recorded as KBr discs in the region of 4000 – 400 cm-1 on an IR Prestige-21 
Shimadzu infrared spectrometer.  Nuclear Magnetic Resonance (NMR) spectra were obtained using a 
Bruker Avance III 300 spectrometer operating at 300 MHz or Bruker Avance III 500 spectrometer 
operating at 500 MHz. All samples were dissolved in d6-DMSO. Chemical shifts, δ, are given in ppm 
and coupling constants, J, are given in Hz. All 
1
H-NMR spectra were recorded in the region of -5 ppm 
to 15 ppm from TMS with a resolution of 0.18 Hz or 0.0006 ppm. All 
13
C-NMR spectra were 
recorded in the region -33 ppm to 233 ppm from TMS with a resolution of 0.008 ppm. The elemental 
composition analyses (%CHN) were carried out in the Microanalytical Laboratory, Department of 
Chemistry, University College Dublin, Belfield, Dublin 4. Thermogravimetric analysis (TGA) was 
carried out on a Universal V4.5A TA Instrument Q50 in ITT Dublin. Melting point values were 
recorded on a Stuart scientific SMP1 melting point apparatus in ITT Dublin, and were taken up to a 
temperature of 390 ºC. An Orion 710A pH-meter equipped with a Metrohm combined electrode (type 
6.0234.100) and a Metrohm 665 Dosimat burette were used for the titrations. A Hewlett Packard 
8452A diode array spectrophotometer was used to record the UV-vis spectra in the 200 to 950 nm 
window. The path length was 1 cm All EPR spectra were recorded with a BRUKER EleXsys E500 
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spectrometer (microwave frequency 9.81 GHz, microwave power 10 mW, modulation amplitude 5 G, 
modulation frequency 100 kHz). The isotropic EPR spectra were recorded at room temperature in a 
circulating system. 
Synthesis of Coumarin-derived Schiff base ligand (L7) and copper(II) complexes (1 and 7) 
The synthesis of L1-L6 and complexes 2-6 were previously published, details given in Supplementary 
Information.
20,27 
Synthesis of Complex 1: Bis[7-(3-ethoxy-2-hydroxybenzylideneamino)-4-
methylcoumarin]copper(II).0.33 hydrate 
 
L1 (0.66 g, 2 mmol), was dissolved in 40 mL EtOH, to which a solution of copper(II) acetate 
monohydrate (0.20 g, 1 mmol) dissolved in 50 mL EtOH was added. The mixture was heated to reflux 
for 16 h and the brown solution was allowed to cool to room temperature. The brown precipitate was 
filtered off and washed with water, air dried and then dried overnight at 40 ºC. Yield: 0.42 g, (58.8%); 
CuC38H3.7N2O8.3; 714.23 g/mol; MP 268-271 ˚C; IR (KBr, cm
-1
): 1728, 1597, 1539, 1439, 1389, 1219, 
1142, 1069, 858, 7410; Microanalysis found: %C 63.90 %H 4.61 %N 3.92, Theoretical: %C 64.45 
%H 4.55 %N 3.96; Solubility: hot acetonitrile, DMSO; Colour: brown. 
 
Synthesis of L7: 7-(2,3,4-trihydroxybenzylideneamino)-4-methylcoumarin 
 
7-amino-4-methylcoumarin (0.70 g, 4 mmol), was dissolved in 30 mL EtOH, to which a solution of 
2,3,4-trihydroxybenzaldehyde (0.63 g, 4 mmol) in 40 mL EtOH was added with a few drops of glacial 
acetic acid. The mixture was brought to reflux for 16 h and left to cool to room temperature. The red 
solution was filtered and washed with cold EtOH and left to air dry and then dried in an oven 
overnight at 40 ºC.  
Yield: 0.98 g (78.7%); C17H13NO5; 311.29 g/mol; MP decomposes at 277 ºC; IR (KBr): 3441, 1705, 
1639, 1601, 1554, 1366, 1296, 1157, 1134, 1072, 858, 609, 440 cm-1; Microanalysis: %C 65.14 %H 
4.05 %N 4.31, Theoretical: %C 65.59 %H 4.21 %N 4.50; 1H-NMR (d6-DMSO, 300 MHz, ppm, Hz): 
δ = 8.90 [s, 1H, H13(-CH=N-)], δ = 7.84 (d, 1H, Ar-H5, J = 8.3), δ = 7.44 (d, 1H, Ar-H8, J = 1.9), δ = 
7.40 (dd, 1H, Ar-H6, J = 8.5 J = 2.0), δ = 7.02 (d, 1H, Ar-H19, J = 8.5), δ = 6.47 (d, 1H, Ar-H18, J = 
8.6), δ = 6.40 [(s, 1H, H3 (vinyl)], δ = 2.45 [s, 3H, (CH3)]; )]; 13C-NMR: C13 – 165.39, C2 – 160.38, 
C4, C7, C9, C15 and C17(R2) 151.61-154.49, C16(R1) – 132.88, C5 – 126.88, C19 – 125.17, C6 and 
C14 118.65 – 118.06, C3 – 113.75, C10 – 112.83, C18(R3) – 108.64, C8 – 108.61, C11(CH3) – 
18.60; Solubility: DMSO, DMF; Colour: red.  
 
 
Synthesis of Complex 7: Bis[7-(2,3,4-trihydroxybenylideneamino)-4-methylcoumarin]copper(II) 
trihydrate 
 
L7, 7-(2,3,4-trihydroxybenzylideneamino)-4-methylcoumarin (1.24 g, 4 mmol), was dissolved in 40 
mL EtOH, to which was added a solution of copper(II) acetate monohydrate (0.40 g, 2 mmol) in 40 
mL EtOH was added. The brown solution was brought to reflux for 16 h and left to cool to room 
temperature. The product was filtered and washed with cold EtOH and left to air dry and then dried in 
an oven overnight at 40 ºC.  
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Yield: 0.43 g (29.1%); CuC34H30N2O13; 738.16 g/mol; IR (KBr): 3441, 1732, 1701, 1643, 1601, 1312, 
1150 cm
-1
; Microanalysis: Found: %C 54.53 %H 3.26 %N 3.57, Theoretical: %C 55. 32 %H 4.10 %N 
3.80; Solubility: DMSO, DMF; Colour: brown. 
 
Speciation studies  
 
Potentiometric titrations and calculations 
The pH-potentiometric measurements for the determination of the proton dissociation constants of L1 
and L7 and the overall stability constants of the Cu(II) complexes were carried out at 25.0±0.1 
o
C in 
DMSO:water 80:20 (v/v) as solvent. An ionic strength of 0.10 M (KCl) used in order to keep the 
activity coefficients constant. The titrations were performed with carbonate-free KOH solution of 
known concentration (0.10 M). The concentrations of the base and the HCl were determined by pH-
potentiometric titrations. The electrode system was calibrated to the pH = −log[H+] scale in the 
DMSO/water solvent mixture by means of blank titrations (strong acid vs. strong base: HCl vs. KOH), 
similarly to the method suggested by Irving et al. in pure aqueous solutions.
42
 The average water 
ionization constant pKw was 18.7±0.1, which corresponds well to the literature data.
27
 The 
reproducibility of the titration points included in the calculations was within 0.01 pH. The pH-metric 
titrations were performed in the pH range 2.0-15.5. The initial volume of the samples was 10.0 mL. 
The ligand concentration was 1 mM and metal ion-to-ligand ratios of 1:1-1:3 were used. Samples 
were deoxygenated by bubbling purified argon through them for approximately 10 minutes prior to 
the measurements. Argon was also passed over the solutions during the titrations. The exact 
concentration of the ligand stock solutions together with the proton dissociation constants were 
determined by pH-potentiometric titrations with the use of the computer program HYPERQUAD.
43
 
The same program was also utilized to establish the stoichiometry of the complexes and to calculate 
the stability constants (log(MpLqHr)). ( (MpLqHr) is defined for the general equilibrium pM + qL + 
rH  MpLqHr as ( (MpLqHr) = [MpLqHr]/[M]
p
[L]
q
[H]
r
, where M denotes the metal ion and L the 
completely deprotonated ligand. In all calculations exclusively titration data were used from 
experiments in which no precipitate was visible in the reaction mixture. 
UV-vis spectrophotometric titrations and spectrofluorimetry 
Proton dissociation constants and molar absorbance spectra of the individual ligand species were 
calculated using the computer program PSEQUAD.
44
 The spectrophotometric titrations were 
performed on samples containing the ligand at 48 µM concentration in the pH range from 2-14.5 at 
25.0±0.1 °C in DMSO:water 80:20 (v/v) at an ionic strength of 0.10 M (KCl).  
Three-dimensional fluorescence spectra were recorded at 250-450 nm excitations, and at 300-600 nm 
emission wavelengths on a Hitachi-4500 spectrofluorimeter in a 1 cm quartz cell at 25.0±0.1 
o
C. 
Samples contained 0.2 µM Schiff base ligand in DMSO:water 80:20 (v/v) at 0.1 M (KCl) ionic 
strength.  
EPR spectroscopic measurements and deconvolution of the spectra 
The stock solution contained 1 or 2 mM ligand and 1 mM or 0.67 mM CuCl2 in 80% (v/v) 
DMSO/H2O at an ionic strength of 0.10 M (KCl). KOH solution was added to the stock solution to 
change the pH, which was measured with a Radiometer PHM240 pH/ion Meter equipped with a 
Metrohm 6.0234.100 glass electrode. A Heidolph Pumpdrive 5101 peristaltic pump was used to 
circulate the solution from the titration vessel through a capillary tube into the cavity of the 
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instrument. The titrations were carried out under a nitrogen atmosphere. The pH range covered was 2–
14.5. For several pH values 0.10 mL of sample was taken out of the stock solution and was measured 
individually in a Dewar containing liquid nitrogen (at 77 K).  
The anisotropic spectra were analyzed individually with the EPR program,
45
 which gives the 
anisotropic EPR parameters (gx, gy, gz, Ax, Ay, Az, ax
N
, ay
N
, az
N
), and the orientation dependent linewidth 
parameters (relaxation parameters  define the linewidths through the equation 
MI=+MI+MI
2
, where MI denotes the magnetic quantum number of copper nucleus). Since a 
natural CuCl2 was used for the measurements, the spectra were calculated as the sum of the spectra of 
63
Cu and 
65
Cu weighted by their natural abundances. The copper and nitrogen coupling constants and 
the relaxation parameters were obtained in field units (Gauss = 10
−4
 T). 
Evaluation of SOD and CAT mimetic activity using chemical assays 
Procedures for both assays have been published previously and full details are given in 
Supplementary Information.
19, 46
  
 
In vivo anti-oxidant studies  
Evaluation of antioxidant activity in wild type BY4741 of Schiff base ligands, copper(II) complexes 
and copper salts  
To determine SOD and CAT activity in S. cerevisiae wild type cells, cells were grown in 2% YPD to 
a concentration of 0.5-0.6 mg dry weight/cm
3
 over 18-21 h in an orbital shaker at 28 ºC and 160 rpm. 
A volume of culture with a ratio of conical flask volume/culture medium of 5/1 (either 5 or 10 mL in 
a 25 or 50 mL conical flask) were pre-treated with 100 μM Schiff base ligands, copper(II) complexes 
or copper salts for 2 h in an orbital shaker at 28 ˚C and 160 rpm. The cells were then exposed to a 
stressor, 30 mM menadione (a superoxide generator to determine SOD activity) or 2 mM hydrogen 
peroxide (to determine CAT activity) for 1 h in the orbital shaker.  
Evaluation of SOD activity of selected copper(II) complexes in wild type BY4741 and sod1∆ mutant 
cells  
To determine SOD activity exhibited by the selected complexes, BY4741 wild type and sod1∆ mutant 
cells were grown concurrently in 2% YPD to a concentration of 0.5-0.7 mg dry weight/cm
3
 over 18-
21 h in an orbital shaker at 28 ºC and 160 rpm. A volume of culture with a ratio of conical flask 
volume/culture medium of 5/1 (either 5 or 10 mL in a 25 or 50 mL conical flask) were pre-treated 
with 100 μM of selected copper(II) complexes for 2 h in an orbital shaker at 160 rpm 28 ˚C. The cells 
were then exposed to a stressor, with wild type cells treated with 10 mM menadione and sod1∆ 
mutant cells treated with the lower concentration of 1.2 mM menadione.  
Statistical analysis 
All data displayed in the tables and graphs for the wild type cell studies were analysed in GraphPad 
Prism 7 software using the statistical method one-way analysis of variance, ANOVA, at P<0.05 by 
means of Dunnett’s multiple comparisons test. ns denotes results with no statistical significance,  * 
and ** denote statistical significance, where * indicates significant results with a P value between 
>0.01<0.05 and ** denotes very significant results with a P value between >0.001<0.01.  A grey row 
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between data indicates the complex or ligand was tested in a separate assay with its own untreated 
positive control (cells treated with stressor only). 
Cytotoxicity assay  
 
MCF-7 Human Breast Cancer cells were sourced from the American Tissue Culture Collection 
(ATCC, USA). MCF-7 cells are an adherent cell line which were grown in Minimum Essential 
Medium Eagle with 1% (v/v) L-glutamine, 1% (v/v) penicillin-streptomycin solution containing 
10000 units penicillin and streptomycin 10 mg/mL, 10% (v/v) Fetal Bovine Serum, 1% v/v sodium 
pyruvate 100 mM solution and 1% (v/v) MEM Non-Essential Amino Acid solution 100X. Cells were 
cultured in T75 cm
2
 tissue culture flasks at 37 ºC in a humidified atmosphere with 5% CO2. Cells 
were used between passages 6-21. Thiazolyl Blue Tetrazolium Bromide (MTT) cytotoxicity assay in 
MCF-7 cells was carried out according to a previously published procedure.
20
  
ROS assay using 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) fluorescent dye 
 
MCF-7 cells were diluted to a concentration of 1 x 10
5 
cells per mL in MEM phenol red-free media. 
100 µL of this cell suspension solution was added to microwells of a black-sided clear-bottomed 96 
well plate, seeded in rows 2-12 only leaving row 1 cell free, and incubated for 24 h at 37 °C at 95% 
humidity and 5% CO2. After this incubation period, media was gently removed from each microwell 
and washed twice with 100 µL of sterile PBS.  The cells are then treated with the following solutions: 
A working stock of 10 µM 2',7'-dichlorodihydrofluorescein diacetate, DCF-DA, was prepared from a 
2 mM stock solution in pure DMSO and diluted to 10 µM in PBS, giving a 0.5% v/v DMSO working 
stock solution. This working stock was added to 8 microwells in rows 1 and 2 and used as the diluent 
to prepare the 8 replicates of the positive controls. TBHP was made fresh immediately prior to plating 
the test solutions. 40 mM stock solutions of complex were prepared in pure DMSO and 100 µM 
complex or ligand solutions were prepared, giving a total of 0.5% (v/v) DMSO/PBS. 0.78 µM-100 
µM of complexes were used to treat 8 replicate microwells.  All microwells contained 0.5% (v/v) 
DMSO/PBS, (with exception to the positive control in row 3, the DMSO control), which was found to 
be the highest concentration of DMSO that was tolerable to the MCF-7 cells in a previous 
optimisation assay. Once all solutions had been added to the plate, fluorescent readings were 
measured on a Biotek Synergy H1 Hybrid Multi-mode Reader over 3 h at an excitation wavelength 
495 nm and  emission wavelength 527 nm, at a gain setting of 85 and an incubation temperature of 37 
°C. The plate was returned to the incubator at a temperature of 37 °C at 95% humidity and 5% CO2 
between readings. The 8 replicates of working stock were used as a blank. This data was expressed as 
ROS induction as a fold increase on the negative control of cells (row 2) for each corresponding time-
point. The error bars were expressed as standard error of the mean, SEM, of at least 3 independent 
experiments when measuring the pro-oxidant activity of the complexes and at least two independent 
experiments for measuring the ligands. ROS generation results are presented in graphs displayed in 
Supplementary Information, unless presented here. Statistical analysis was determined using the 
Graphpad Prism 7 package, and Dunnett’s multiple comparisons test was used to determine statistical 
significance with significance level set at 0.05.  
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Abbreviations 
 
CAT  catalase 
CT-DNA calf-thymus-DNA 
DCF  2',7'-dichlorofluorescein  
DMF  dimethylformamide 
DMSO  dimethyl sulfoxide 
EDTA  Ethylenediaminetetraacetic acid 
EtOH  Ethanol 
H2DCFDA  2',7'-dichlorodihydrofluorescein diacetate 
HPCINOL 1-[bis(pyridine-2-ylmethyl)amino]-3-chloro-propan-2-ol  
MEM  Minimum Essential Medium  
MTT   methylthiazolyldiphenyltetrazolium bromide 
NBT   nitro blue tetrazolium 
NSAIDs non-steroidal anti-inflammatory drugs 
PBS   phosphate-buffered saline 
phen  phenanthroline 
ROS   Reactive oxygen Species 
RNS   reactive nitrogen species 
SC  supercoiled 
SEM  standard error of the mean  
SOD  superoxide dismutase 
TBHP  tert-butyl hydroperoxide  
TGA  thermogravimetric analysis 
YPD   Yeast Extract–Peptone–Dextrose  
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Scheme 1: General synthetic scheme for coumarin-derived Schiff bases ligands and their copper 
complexes (Substituents R
1
, R
2
 and R
3
 given in Figure 1) 
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Figure 1: Proposed solid state structure of copper(II) complexes of  coumarin-derived Schiff 
base ligands 
 
  
Complex R
1
 R
2
 R
3
 
1 OCH2CH3 H H 
2 H H NO2 
3 OCH3 H NO2 
4 OH H H 
5 OCH3 H H 
6 I H I 
7 OH OH H 
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Figure 2: UV-visible spectra recorded at various pH values for L7 (a); concentration of 
distribution curves (solid lines) together with absorbance values at 460 nm up to pH 10.4 (×) 
(b); calculated molar absorbance spectra of H3L and H2L
-
 species (c). (80% (v/v) 
DMSO/H2O; T = 25 °C, I = 0.10 M (KCl); cL = 48 M; l = 1 cm)  
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Figure 3: 3D-fluorescence spectrum of L1 (a) and L7 (b) at neutral pH (9.35) in 80% (v/v) 
DMSO/H2O under the same condition (T = 25 °C, I = 0.10 M (KCl); cL = 1 M; l = 1 cm).  
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Figure 4: pH-potentiometric titration curves recorded for the Cu(II) – L7 system: ligand 
alone (×); Cu:L7 = 1:3 (▲), 1:2 (○), 1:1 (■). (80% (v/v) DMSO/H2O; T = 25 °C, I = 0.10 M 
(KCl)) 
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Figure 5: EPR spectra recorded at various pH values for the Cu(II) – L1 system at 1:1 (a) 
and 1:3 (b) metal-to-ligand ratio (black lines) together with the simulated spectra (red lines). 
(80% (v/v) DMSO/H2O; T = 77 K, I = 0.10 M (KCl); cCu(II) = 1 mM (a), 0.67 mM (b)) 
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Figure 6: Concentration of distribution curves of the Cu(II) – L1 system on the basis of the 
determined stability constants using pH-potentiometry (model I: black lines, model II: grey 
lines). (80% (v/v) DMSO/H2O; T = 25 °C, I = 0.10 M (KCl); cCu(II) = cL = 1 mM)  
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Figure 7: Calculated component EPR spectra obtained for species formed in the Cu(II) – L1 
system. (80% (v/v) DMSO/H2O; T = 77 K, I = 0.10 M (KCl)) 
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Figure 8: Concentration of distribution curves of the Cu(II) – L7 system on the basis of the 
determined stability constants using pH-potentiometry (model I: black lines, model II: grey 
lines). (80% (v/v) DMSO/H2O; T = 25 °C, I = 0.10 M (KCl); cCu(II) = cL = 1 mM)  
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Figure 9: Effect of biomimetics on the survival rates of S. cerevisiae wild type cells exposed 
to oxidative stress. Cells were preincubated with 100 μM of complex for 2 h (a) complexes 1-
3 and (b) 4-7, and then exposed to 30 mM menadione, a superoxide generator. Cells were 
cultured in 2% YPD medium and cell viability was measured by plating in triplicate on 2% 
YPD solid medium and expressed as percentage of survival relative to a negative control. The 
results represent the mean ± SEM of at least three independent experiments.  
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Figure 10: Effect of the biomimetics on the survival rates of S. cerevisiae wild type cells 
exposed to oxidative stress. Cells were preincubated with 100 μM of complex for 2 h, a) 1-3, 
b) 4-6 and c) 7, and then exposed to 2 mM H2O2. Cells were cultured in 2% YPD medium 
and cell viability was measured with and without exposure to oxidative stress by plating in 
triplicate on 2% YPD solid medium and expressed as percentage of survival relative to a 
negative control. The results represent the mean ± SEM of at least three independent 
experiments.  
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Figure 11: Effect of the biomimetics on the survival of S. cerevisiae sod1∆ mutant cells 
when exposed to oxidative stress. Cells were preincubated with 100 μM of complexes 4-6 for 
2 h and then exposed to 1.2 mM menadione. Cells were cultured in 2% YPD medium and cell 
viability was measured with and without exposure to oxidative stress by plating in triplicate 
on 2% YPD solid medium and expressed as percentage of survival relative to a negative 
control. The results represent the mean ± SEM of at least three independent experiments.  
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Figure 12: Endogenous ROS induction in breast cancer cell line (MCF-7) after exposure to 
ROS probe 2',7'-dichlorodihydrofluorescein diacetate and increasing concentrations of 
complexes 1 and 2 over a time-course of 0-180 min. (Data for remaining complexes given in 
Supplementary Information)   
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Table 1: IR bands for coumarin-derived Schiff base ligands and their complexes 
Ligand 
ν(CH=N) 
cm
-1 
ν(C=O) 
cm
-1
 
ν(C-O) 
cm
-1
 
Complex 
ν(CH=N) 
cm
-1 
ν(C=O) 
cm
-1
 
ν(C-O) 
cm
-1
 
L1 1624 1724 1250 1 unresolved 1728 1219 
L7 1639 1705 1296 7 1643 1701 1312 
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Table 2: Proton dissociation constants (pKa) of L1 and L7 and overall stability constants 
(logβ) of their Cu(II) complexes determined by pH-potentiometric titrations in 80% (v/v) 
DMSO/H2O. (T = 25 C; I = 0.1 M (KCl)) 
  L1 
a
  L7 
 pKa (HL) 9.46 ± 0.03 
b
 pK1 (H3L) 8.41 ± 0.09 
b
 
m
o
d
el
 I
 
log [CuL]+ 6.65 ± 0.09 pK2 (H2L
-
) 13.51 ± 0.07 
log [CuLH-1] -1.34 ± 0.09 pK3 (HL
2-
) 15.30 ± 0.05 
log [CuLH-2]
-
 -12.1 ± 0.1 log [CuLH2]
+
 38.6 ± 0.2 
pKa [CuL]
+
 7.99 log [CuLH] 30.64 ± 0.09 
pKa [CuLH-1] 10.74 log [CuL]
-
 15.8 ± 0.2 
   pKa [CuLH2]
+
 7.52 
   pKa [CuLH] 14.87 
m
o
d
el
 
II
 
log [CuL]+ 6.61 ± 0.08   
log [CuLH-1] -1.34 ± 0.08 log [Cu2L2H4]
2+
 78.7 ± 0.1 
log [Cu2L2H-4]
2-
 -20.8 ± 0.2 log [Cu2L2H2] 62.4 ± 0.1 
a 
Data published for L1:  pKa = 9.28; log [CuL]
+
 = 6.30; log [CuLH-1] = -
1.71; [CuLH-2]
-
 = -12.7; pK [CuL]
+
 = 8.01; pK [CuH-1] = 10.99 in Ref. 27 
b 
L1: 
9.44 ± 0.08; L7: pK1 (H3L) = 8.38 ± 0.02 determined by UV-vis titrations. 
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Table 3. EPR parameters at 77 K for the Cu(II) complexes of L1 in 80% (v/v) DMSO/ H2O
 a
 
 
 gx, gy gz Ax /G Ay /G Az /G ax
N
/G
 
          
ay
N
/G
   
            
az
N
/G
 
go,calc 
b
 
Cu
2+
 2.0787(1) 2.0787(1) 2.4060(3) 1.5(5)  113.7(2)  2.1878 
[CuL]
+
 
 
 
 
 
 
2.0836(1) 2.0555(1) 2.3559(3) 10.0(1) 14.9(1) 127.2(3)  2.1650 
[CuL(OH)] 2.0649(1) 2.0617(2) 2.3242(3) 0.0(3) 14.2(1) 147.5(2) 
4.7        
9.7         
9.9 
2.1503 
[Cu2L2(OH)4]
2‒
 inactive        
a 
The confidence intervals of the parameters regarding the last digit are given in parentheses. 
The hyperfine coupling constants and the relaxation parameters are given in G (10
-4
 T) units, 
and refer to the isotope 63Cu. 
b 
Calculated isotropic values via the equation go = (gx+gy+gz)/3.  
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Table 4: Summary of IC50 values of complexes 1-7 (µM) measured after 24 h against MCF-7 
breast cancer cell line. Values calculated from 3 independent experiments. 
Series Ref Complex  IC50 values (µM ± SEM) 
S
ch
if
f 
b
as
e 
co
m
p
le
x
es
 
 
1 69.3 ± 7.6 
20
 2 >100* 
20
 3 34.5 ± 6.1*  
20
 4 >100* 
20
 5 >100* 
20
 6 79.8 ± 4.6*  
  6 63.8 ± 4.6  
  7 >100 
D
ru
g
   20 
Mitoxantrone 15.0 ± 8.7* 
 
20 
Doxorubicin 71.6 ± 1.5* 
Ctrl 
3, 25,20
 CuSO4 >100* 
 
* IC50 values from  reference 20. These values were measured in the same laboratory as those reported for the 
current work using the same cell line
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Table 5: Coumarin-derived Schiff base complexes and their in vitro SOD and CAT activities. 
SOD activity are expressed as an IC50 (μM), which is the concentration of complex required 
to inhibit 50% of the blue formazan formation. CAT activity was measured via the volume of 
oxygen evolved from a reaction vessel containing 10 cm
3
 of 35% aqueous H2O2 in the 
presence of 10 mg of complex and 50 mg of imidazole base. 
Complex No. R
1
 R
2
 R
3
 
SOD 
Activity 
IC50 ± 0.5 
(μM) 
CAT Activity Volume of 
O2 Evolved (mL/min) 
1 OCH2CH3 H H - - 
2 H H NO2 1.15 13.5 
3 OCH3 H NO2 0.99 23.9 
4 OH H H 1.39 7.9 
5 OCH3 H H 1.08 4.7 
6 I H I 0.85 inactive 
7 OH OH H - - 
Veterinary drug [Cu2(indo)4(H2O)2] 1.31  
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Table 6: Apparent Binding DNA Constants (Kapp) of complexes 1-7 and drug controls 
actinomycin D and pentamidine. 
Complex 
Fluorescent Inhibition 
>50% 
(0-150 µM of complex) 
C50 
(µM) 
Kapp (M(bp)
-1
) 
Actinomycin D 
LML 
Yes 9.18 1.54 x 10
7
 
Pentamidine No 
 
n/a n/a 
1 No n/a n/a 
2 No n/a n/a 
3 No n/a n/a 
4 No n/a n/a 
5 No n/a n/a 
6 Yes 83.74 1.43 x 10
6
 
7 Yes  47.02 2.55 x 10
6
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Graphical Abstract for paper entitled “Copper(II) complexes of coumarin-derived Schiff base ligands: 
Pro- or antioxidant activity in MCF-7 cells?” 
Schiff base-derived copper(II) complexes were investigated in breast cancer MCF-7 and yeast cells 
for their pro-and antioxidant behaviour.  Cytotoxic complexes did not generate reactive oxygen 
species or cause damage to DNA, in contrast to similar copper(II) complexes previously studied. 
Speciation studies on two of the complexes were also carried out.  
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Highlights of paper entitled “Copper(II) complexes of coumarin-derived Schiff base ligands: 
Pro- or antioxidant activity in MCF-7 cells?” 
 
 Study of copper(II) complexes pro- and antioxidant activity in yeast and mammalian cells 
 Determination  of solution behaviour at physiological pH of two copper(II) complexes  
 Correlation of solution structure with anticancer activity of the copper(II) complexes 
 Identification of unusual antioxidant properties of copper(II)-based therapeutics  
 Comparison to previous copper(II) complexes studied  
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